Acute Ischemic Stroke Diagnosis Global Market Report 2024

Description

An acute ischemic stroke (AIS) diagnosis involves identifying a medical condition characterized by a sudden loss of blood flow to a specific part of the brain, leading to a loss of neurological function. The diagnostic process aims to pinpoint and understand the origins of the clot responsible for the abrupt reduction in blood flow.

The primary types of acute ischemic stroke diagnosis include computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and other relevant methods. Computed tomography (CT) involves the creation of detailed images of various body parts using computer technology connected to an X-ray machine. Various types of surgeries are associated with acute ischemic stroke treatment, including carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. These surgical procedures find application in various treatment approaches, such as the use of tissue plasminogen activator (TPA), anticoagulants, antiplatelet medications, and antihypertensive drugs.

The acute ischemic stroke diagnosis market research report is one of a series of new reports from The Business Research Company that provides acute ischemic stroke diagnosis market statistics, including acute ischemic stroke diagnosis industry global market size, regional shares, competitors with an acute ischemic stroke diagnosis market share, detailed acute ischemic stroke diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke diagnosis industry. This acute ischemic stroke diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.14 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the rise in cardiovascular risk factors, increased adoption of telemedicine, the establishment of specialized stroke centers, a growing aging population, and advancements in thrombolytic therapies. These elements collectively contributed to the overall progress and improvement in the field of acute ischemic stroke diagnosis and treatment.

The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to various factors, including the integration of remote monitoring technologies, the adoption of patient-centric healthcare models, the incorporation of wearable devices, the development of point-of-care testing devices, and the expansion of mobile stroke units. Key trends expected in the forecast period include advancements in imaging technologies, the application of artificial intelligence in diagnostics and treatment, innovations in genetic and biomarker products, the use of blockchain for data security, and the integration of augmented reality in healthcare applications. These trends collectively contribute to the continued evolution and improvement of acute ischemic stroke diagnosis and care.

The anticipated surge in acute ischemic stroke cases stands as a driving force behind the projected growth of the acute ischemic stroke diagnosis market. This medical condition, stemming from inadequate blood supply to the brain, leads to severe brain cell damage and qualifies as a critical medical emergency. Prompt diagnosis of acute ischemic stroke becomes instrumental in its treatment, mitigating potential brain damage, and curtailing subsequent repercussions. An illustrative instance from March 2023 reported by the Centers for Disease Control and Prevention highlighted an increase in stroke-related fatalities from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. In the United States alone, the annual occurrence exceeds 795,000 strokes, with approximately 610,000 being first-time strokes, and approximately 87% of these strokes are ischemic in nature, indicating impaired blood flow to the brain. Hence, the escalating prevalence of acute ischemic stroke cases drives the expansion of the acute ischemic stroke diagnosis market.

The burgeoning elderly demographic is poised to significantly contribute to the growth of the acute ischemic stroke diagnosis market in the foreseeable future. Defined as individuals aged 65 and above, this demographic segment presents distinct health and social requisites coupled with vulnerabilities associated with the aging process, such as the prevalence of multiple chronic ailments and physical limitations. The elderly demographic assumes a pivotal role in acute ischemic stroke diagnosis, primarily due to their heightened susceptibility compared to younger age groups. Key facets crucial in acute ischemic stroke diagnosis encompass early identification, treatment modalities, and concurrent health conditions. For instance, insights from the World Health Organization in October 2022 indicated that by 2030, 1 in every 6 individuals globally will surpass 60 years of age, reaching a tally of 1.4 billion, up from 1 billion in 2020. Moreover, the worldwide population aged 60 and above is projected to double to 2.1 billion by 2050, with an additional 426 million individuals expected to cross the 80-year milestone during this period. Hence, the burgeoning elderly populace is a significant catalyst propelling the expansion of the acute ischemic stroke diagnosis market.

The acute ischemic stroke diagnosis market is witnessing a prominent trend favoring product innovations, capturing widespread attention. Leading companies within this domain are dedicatedly engaged in pioneering novel products to uphold their market standing. An exemplary instance occurred in February 2022 when Imperative Care Inc., a US-based manufacturer of medical equipment, unveiled the Zoom POD Aspiration Tubing-an innovative advancement aimed at enhancing stroke therapy. Distinguished as the first sterile field clot filter device, the Zoom POD facilitates expedited mechanical thrombectomy procedures for individuals afflicted with ischemic stroke. This groundbreaking device integrates seamlessly into the aspiration tube, significantly reducing the distance between aspiration and filtration while maintaining optimal aspiration strength. The Zoom POD expedites a critical phase of treatment by providing swift visualization to physicians, confirming efficient clot removal, thereby streamlining the therapeutic process.

Major players in the acute ischemic stroke diagnosis market are strategically forging partnerships to gain a competitive edge. These collaborations are strategically aimed at bolstering the development and accessibility of cutting-edge diagnostic tools crucial for accurate and timely stroke diagnosis. Notably, in October 2023, Brainomix Ltd., a US-based medtech company powered by AI solutions, joined forces with Nanoflex Robotics AG, a Switzerland-based developer specializing in soft robotic systems. Their partnership targets the creation of an AI robotics platform dedicated to acute ischemic stroke treatment. This innovative platform involves AI-assisted magnetic navigation systems tailored for stroke-related robotic surgical tools. The amalgamation of their technologies aims to introduce an AI-driven navigation tool facilitating catheters and other devices in navigating the vascular system. This collaborative project aspires to leverage artificial intelligence to enhance Nanoflex Robotics' advanced magnetic robotic navigation system, potentially pioneering remote thrombectomy-a groundbreaking shift in stroke therapy possibilities. This groundbreaking endeavor is anticipated to significantly impact stroke therapy, potentially enhancing patient outcomes by revolutionizing the treatment landscape.

In November 2021, Royal Philips, a Netherlands-based hospital and healthcare company, completed the acquisition of Cardiologs for an undisclosed amount. This strategic move allowed Philips to enhance its cardiac monitoring and diagnostics portfolio by incorporating innovative software technologies, electrocardiogram (ECG) analysis, and reporting services. Cardiologs, based in France, is a medical technology company specializing in ECG, a diagnostic tool relevant to acute ischemic stroke and other cardiovascular conditions.

Major companies operating in the acute ischemic stroke diagnosis market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Genentech Inc., Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Penumbra Inc., Insera Therapeutics LLC, MicroVention Inc., FUJIFILM Medical Systems, Canon Medical Systems Corporation, Silk Road Medical Inc., Samsung Neurologica Corporation, Mentice AB, NICO Corporation, Imperative Care Inc., Olea Medical, NovaSignal Corporation, iSchemaView Inc., Hyperfine Research Inc., Perfuze Ltd.

North America was the largest region in the acute ischemic stroke diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute ischemic stroke (AIS) diagnosis market includes revenues earned by entities through physical exams, thrombolysis, blood tests, and other imaging techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Ischemic Stroke Diagnosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute ischemic stroke diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute ischemic stroke diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute ischemic stroke diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Diagnostic Type: Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Carotid Ultrasound; Cerebral Angiography; Electrocardiography (ECG); Echocardiography; Other Diagnostics
2) By Surgery Type: Carotid Endarterectomy; Angioplasty; Endovascular Mechanical Thrombectomy
3) By Application: Tissue Plasminogen Activator (TPA); Anticoagulant; Antiplatelet; Antihypertensive
Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Sanofi-Aventis LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13521

1. Executive Summary

2. Acute Ischemic Stroke Diagnosis Market Characteristics

3. Acute Ischemic Stroke Diagnosis Market Trends And Strategies

4. Acute Ischemic Stroke Diagnosis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Acute Ischemic Stroke Diagnosis Market Size and Growth

5.1. Global Acute Ischemic Stroke Diagnosis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Acute Ischemic Stroke Diagnosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Acute Ischemic Stroke Diagnosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Ischemic Stroke Diagnosis Market Segmentation

6.1. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography (ECG)
Echocardiography
Other Diagnostics
6.2. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Carotid Endarterectomy
Angioplasty
Endovascular Mechanical Thrombectomy
6.3. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tissue Plasminogen Activator (tPA)
Anticoagulant
Antiplatelet
Antihypertensive

7. Acute Ischemic Stroke Diagnosis Market Regional And Country Analysis

7.1. Global Acute Ischemic Stroke Diagnosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Acute Ischemic Stroke Diagnosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

8.1. Asia-Pacific Acute Ischemic Stroke Diagnosis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Ischemic Stroke Diagnosis Market

9.1. China Acute Ischemic Stroke Diagnosis Market Overview
9.2. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Ischemic Stroke Diagnosis Market

10.1. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Ischemic Stroke Diagnosis Market

11.1. Japan Acute Ischemic Stroke Diagnosis Market Overview
11.2. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Ischemic Stroke Diagnosis Market

12.1. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Ischemic Stroke Diagnosis Market

13.1. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Ischemic Stroke Diagnosis Market

14.1. South Korea Acute Ischemic Stroke Diagnosis Market Overview
14.2. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Ischemic Stroke Diagnosis Market

15.1. Western Europe Acute Ischemic Stroke Diagnosis Market Overview
15.2. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Ischemic Stroke Diagnosis Market

16.1. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Ischemic Stroke Diagnosis Market

17.1. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Ischemic Stroke Diagnosis Market

18.1. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Ischemic Stroke Diagnosis Market

19.1. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Ischemic Stroke Diagnosis Market

20.1. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Ischemic Stroke Diagnosis Market

21.1. Eastern Europe Acute Ischemic Stroke Diagnosis Market Overview
21.2. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Ischemic Stroke Diagnosis Market

22.1. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Ischemic Stroke Diagnosis Market

23.1. North America Acute Ischemic Stroke Diagnosis Market Overview
23.2. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Ischemic Stroke Diagnosis Market

24.1. USA Acute Ischemic Stroke Diagnosis Market Overview
24.2. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Ischemic Stroke Diagnosis Market

25.1. Canada Acute Ischemic Stroke Diagnosis Market Overview
25.2. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Ischemic Stroke Diagnosis Market

26.1. South America Acute Ischemic Stroke Diagnosis Market Overview
26.2. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Ischemic Stroke Diagnosis Market

27.1. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Ischemic Stroke Diagnosis Market

28.1. Middle East Acute Ischemic Stroke Diagnosis Market Overview
28.2. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Ischemic Stroke Diagnosis Market

29.1. Africa Acute Ischemic Stroke Diagnosis Market Overview
29.2. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Ischemic Stroke Diagnosis Market Competitive Landscape And Company Profiles

30.1. Acute Ischemic Stroke Diagnosis Market Competitive Landscape
30.2. Acute Ischemic Stroke Diagnosis Market Company Profiles
- 30.2.1. Cardinal Health Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sanofi-Aventis LLC
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Acute Ischemic Stroke Diagnosis Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Medtronic plc
31.3. Siemens Healthineers AG
31.4. Philips Healthcare
31.5. Stryker Corporation
31.6. GE HealthCare Technologies Inc.
31.7. Boston Scientific Corporation
31.8. Genentech Inc.
31.9. Nihon Kohden Corporation
31.10. Neusoft Medical Systems Co. Ltd.
31.11. Penumbra Inc.
31.12. Insera Therapeutics LLC
31.13. MicroVention Inc.
31.14. FUJIFILM Medical Systems
31.15. Canon Medical Systems Corporation

32. Global Acute Ischemic Stroke Diagnosis Market Competitive Benchmarking

33. Global Acute Ischemic Stroke Diagnosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Ischemic Stroke Diagnosis Market

35. Acute Ischemic Stroke Diagnosis Market Future Outlook and Potential Analysis

35.1 Acute Ischemic Stroke Diagnosis Market In 2028 - Countries Offering Most New Opportunities
35.2 Acute Ischemic Stroke Diagnosis Market In 2028 - Segments Offering Most New Opportunities
35.3 Acute Ischemic Stroke Diagnosis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer